Carl Zeiss Meditec AG

AFX

Equity

ISIN DE0005313704 / Valor 1055489

Xetra (2026-10-02)

EUR 31.30+0.32%

Carl Zeiss Meditec AG
UMushroom community rating:

4.40 5 votes No rating yet

NegativeNeutralPositive

About company

Carl Zeiss Meditec AG, headquartered in Jena, Germany and listed on the Frankfurt Stock Exchange, is a medical-technology company focused principally on devices, software and consumables for eye care and microsurgery. Its product portfolio spans diagnostic imaging systems (including optical coherence tomography and retinal imaging), surgical platforms and visualization equipment (such as surgical microscopes and laser systems for refractive and cataract procedures), as well as intraocular lenses, disposables and clinical IT solutions that support workflow and data management. The company sells capital equipment to hospitals, eye clinics and private practices worldwide and generates recurring revenue from consumables, service contracts and software, while investing in research and regulatory approvals to maintain and extend its market position in ophthalmology and related microsurgical fields.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-28.6%1Y

-60.5%3Y

-80.7%5Y

Performance

45.4%1Y

45.2%3Y

42.1%5Y

Volatility

3084 M

Market cap (USD)

128,372

Daily traded volume (Shares)

47.3 / 46.28

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

4.40

5 votes

Performance:

4.20

Innovation:

4.80

Society:

4.40

Nature:

4.20

Luba Schoenig

Switzerland, 08 Jun 2023

Highly innovative company who is expected to be one of the key riders on the virtual reality glasses wave

Tonia Zimmermann

Switzerland, 06 Jun 2023

Big potential ahead of them given the use of their solutions in apple products

Laura Bischofberger

Switzerland, 06 Jun 2023

Interessante Performance über die letzten Jahre. & mit der Vorstellung vom neuen Produkt gestern durch Apple, ist ein gross Auftrag garantiert

EQUITIES OF THE SAME SECTOR

Haemonetics Corp

Haemonetics Corp Valor: 937449

Annual Return

-50%0%+50%

Risk level

110

0.30%USD 104.68

Sanofi SA

Sanofi SA Valor: 699381

Annual Return

-50%0%+50%

Risk level

110

-3.13%EUR 70.81

EssilorLuxottica SA

EssilorLuxottica SA Valor: 497537

Annual Return

-50%0%+50%

Risk level

110

-1.24%EUR 142.80

Eurofins Scientific SE

Eurofins Scientific SE Valor: 58317129

Annual Return

-50%0%+50%

Risk level

110

0.43%EUR 74.86

Legend Biotech Corporation

Legend Biotech Corporation Valor: 54834759

Annual Return

-50%0%+50%

Risk level

110

-3.88%USD 18.57

Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals Inc Valor: 30877188

Annual Return

-50%0%+50%

Risk level

110

-1.05%USD 43.54

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

0.27%USD 22.64

HealthEquity Inc

HealthEquity Inc Valor: 24679014

Annual Return

-50%0%+50%

Risk level

110

0.75%USD 90.04

Ensign Group Inc

Ensign Group Inc Valor: 3109721

Annual Return

-50%0%+50%

Risk level

110

1.27%USD 171.78

Sotera Health Company

Sotera Health Company Valor: 57897071

Annual Return

-50%0%+50%

Risk level

110

0.55%USD 18.22

Logos provided by Clearbit

Carl Zeiss Meditec AG

AFX

ISIN DE0005313704 / Valor 1055489

Carl Zeiss Meditec AG UMushroom community rating:

Luba Schoenig

Tonia Zimmermann

Laura Bischofberger

Carl Zeiss Meditec AG
UMushroom community rating: